Reshaping cAMP nanodomains through targeted disruption of compartmentalised phosphodiesterase signalosomes
- PMID: 31506329
- DOI: 10.1042/BST20190252
Reshaping cAMP nanodomains through targeted disruption of compartmentalised phosphodiesterase signalosomes
Abstract
Spatio-temporal regulation of localised cAMP nanodomains is highly dependent upon the compartmentalised activity of phosphodiesterase (PDE) cyclic nucleotide degrading enzymes. Strategically positioned PDE-protein complexes are pivotal to the homeostatic control of cAMP-effector protein activity that in turn orchestrate a wide range of cellular signalling cascades in a variety of cells and tissue types. Unsurprisingly, dysregulated PDE activity is central to the pathophysiology of many diseases warranting the need for effective therapies that target PDEs selectively. This short review focuses on the importance of activating compartmentalised cAMP signalling by displacing the PDE component of signalling complexes using cell-permeable peptide disrupters.
Keywords: cAMP; cyclic nucleotide phosphodiesterases; peptide array; peptide disruptors.
© 2019 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.
Similar articles
-
Modulation of Compartmentalised Cyclic Nucleotide Signalling via Local Inhibition of Phosphodiesterase Activity.Int J Mol Sci. 2016 Oct 2;17(10):1672. doi: 10.3390/ijms17101672. Int J Mol Sci. 2016. PMID: 27706091 Free PMC article. Review.
-
Optical Mapping of cAMP Signaling at the Nanometer Scale.Cell. 2020 Sep 17;182(6):1519-1530.e17. doi: 10.1016/j.cell.2020.07.035. Epub 2020 Aug 25. Cell. 2020. PMID: 32846156 Free PMC article.
-
PDE2 at the crossway between cAMP and cGMP signalling in the heart.Cell Signal. 2017 Oct;38:76-84. doi: 10.1016/j.cellsig.2017.06.020. Epub 2017 Jun 28. Cell Signal. 2017. PMID: 28668721 Review.
-
Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.Exp Biol Med (Maywood). 2007 Jan;232(1):38-51. Exp Biol Med (Maywood). 2007. PMID: 17202584 Review.
-
In vivo assessment of local phosphodiesterase activity using tailored cyclic nucleotide-gated channels as cAMP sensors.J Gen Physiol. 2001 Jul;118(1):63-78. doi: 10.1085/jgp.118.1.63. J Gen Physiol. 2001. PMID: 11429444 Free PMC article.
Cited by
-
The Role of PDE8 in T Cell Recruitment and Function in Inflammation.Front Cell Dev Biol. 2021 Apr 16;9:636778. doi: 10.3389/fcell.2021.636778. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33937235 Free PMC article. Review.
-
Early Inhibition of Phosphodiesterase 4B (PDE4B) Instills Cognitive Resilience in APPswe/PS1dE9 Mice.Cells. 2024 Jun 8;13(12):1000. doi: 10.3390/cells13121000. Cells. 2024. PMID: 38920631 Free PMC article.
-
Dual Activation of Phosphodiesterase 3 and 4 Regulates Basal Cardiac Pacemaker Function and Beyond.Int J Mol Sci. 2021 Aug 5;22(16):8414. doi: 10.3390/ijms22168414. Int J Mol Sci. 2021. PMID: 34445119 Free PMC article. Review.
-
Disruption of the pro-oncogenic c-RAF-PDE8A complex represents a differentiated approach to treating KRAS-c-RAF dependent PDAC.Sci Rep. 2024 Apr 18;14(1):8998. doi: 10.1038/s41598-024-59451-3. Sci Rep. 2024. PMID: 38637546 Free PMC article.
-
Phosphodiesterase 4D activity in acrodysostosis-associated neural pathology: too much or too little?Brain Commun. 2024 Jun 29;6(4):fcae225. doi: 10.1093/braincomms/fcae225. eCollection 2024. Brain Commun. 2024. PMID: 38983619 Free PMC article. Review.